Zhao D et al. also demonstrated that NPM1-mutated AML, after a previous diagnosis of MDS or MDS/MPN, is enriched in MRGs and has an inferior prognosis compared to de novo NPM1-mutated AML [99]. Here, NPM1 is linked to myeloproliferative disorder.